Literature DB >> 13975093

Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women.

G T ROSS, L L STOLBACH, R HERTZ.   

Abstract

Entities:  

Keywords:  ACTINOMYCIN; CHORIOADENOMA; CHORIOC ARCINOMA; HYDATIDIFORM MOLE; METHOTREXATE

Mesh：

Substances：

Year:  1962        PMID： 13975093

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  THE CHEMOTHERAPY OF MALIGNANT DISEASE--PRACTICAL AND EXPERIMENTAL CONSIDERATIONS.

Authors:  J MATTHIAS
Journal:  Postgrad Med J       Date:  1965-05       Impact factor: 2.401

2.  Endocrinology and treatment of trophoblastic tumours.

Authors:  K D Bagshawe
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

3.  Choriocarcinoma and related trophoblastic tumors in women.

Authors:  R Hertz
Journal:  Calif Med       Date:  1969-03

4.  Prophylaxis of choriocarcinoma.

Authors: 
Journal:  Br Med J       Date:  1968-08-31

5.  Trophoblastic tumors of the uterus-problems of methotrexate therapy.

Authors:  F D Johnson; E M Jacobs; W M Silliphant
Journal:  Calif Med       Date:  1968-01

6.  Update in cancer chemotherapy: genitourinary tract cancer, Part 7: Gestational trophoblastic neoplasms.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-07       Impact factor: 1.798

7.  Actinomycin analogues containing pipecolic acid: relationship of structure to biological activity.

Authors:  J V Formica; A J Shatkin; E Katz
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

8.  Effect of pipecolic acid isomers on the biogenesis of actinomycins.

Authors:  W S May; J V Formica
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

9.  Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies.

Authors:  Jiatao Hao; Weihua Zhou; Mengzhao Zhang; Hui Yu; Taohong Zhang; Ruifang An; Yan Xue
Journal:  BMC Cancer       Date:  2021-10-18       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.